Harnessing Nature's Wisdom: Gene-Editing Therapy For Cardiovascular Disease
2025-09-12 01:10:00 ET
By Shea Wihlborg
Introduction
Cardiovascular disease is the world’s leading killer and one of the most economically damaging, as its prevalence and costs have been rising. 1 While statins can reduce the risk of heart attacks by ~29%, 2 residual risk and poor long-term adherence—roughly half of patients discontinuing after a year—have left millions of people vulnerable. 3 The most common reasons for discontinuing statin treatment include experiencing or fear of developing side effects like muscle pain, perceived lack of benefit, and treatment fatigue from chronic dosing. 4 Not unique to statins, this pattern of poor adherence is widely observed in treatments for other chronic diseases and reflects the broader challenge of sustaining long-term medication use when benefits are not immediately felt and barriers to adherence persist. 5 ...
Read the full article on Seeking Alpha
For further details see:
Harnessing Nature's Wisdom: Gene-Editing Therapy For Cardiovascular Disease
NASDAQ: BBC
BBC Trading
-2.6% G/L:
$41.58 Last:
11,466 Volume:
$42.73 Open:
